December 1, 2021
Representative: Jamie Frankish, Ph.D., Head of Immunology
Presentation/Discussion Round at 9:05 am:
"HERA-Ligand platform as a next-generation agonistic approach in immuno-oncology"
Presentations and Posters from Past Conferences
June 22-24, 2020
Presentation #1076: Hexavalent HERA-CD40L induces a productive T cell-mediated anti-tumor immune response and shows superior activity in comparison to benchmark CD40 agonistic antibodies